Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial
Abstract
Antiviral chemotherapy with famciclovir results in clinically and statistically significant reductions in the symptoms associated with HSV infection and the symptomatic and asymptomatic shedding of HSV among HIV-positive persons.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
adult
female
male
aged
middle aged
P.H.S.
regression analysis
Clinical Trial
Randomized Controlled Trial
Antibodies
Double-Blind Method
Proportional Hazards Models
viral / blood
l corey
antiviral agents / therapeutic use*
cd4 lymphocyte count
cross-over studies
virus activation
virus shedding
aids-related opportunistic infections / drug therapy*
pmid:9424977
doi:10.7326/0003-4819-128-1-199801010-00004
t schacker
h l hu
2-aminopurine / analogs & derivatives*
2-aminopurine / therapeutic use
aids-related opportunistic infections / virology
famciclovir
herpes simplex / drug therapy*
herpes simplex / virology
simplexvirus / growth & development
Access
Citation
ID:
114510
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
114510
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
